Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
INDOMETHACIN AND CELECOXIB IMPAIR ROTATOR CUFF TENDON-TO-BONE HEALING
Professor Martin P Schwellnus, University of Cape Town, South Africa
Background: Non-steroidal anti-inflammatory drugs (non-selective and cyclooxygenase-2-specific) have been shown to impair bone formation, but whether they have a negative effect on tendon-to-bone healing is not known.
Research question/s: Do traditional non-selective non-steroidal anti-inflammatory drugs and cyclooxygenase-2-specific non-steroidal anti-inflammatory drugs negatively affect tendon-to-bone healing.
Methodology:Subjects:180 rats that underwent acute rotator cuff repairs.:Experimental procedure:In the 14 day post-operative period rats were randomly assigned to one of three groups: Control (CON = 60, receiving standard rat chow), Indomethacin (3 mg/kg/day, traditional non-selective anti-inflammatory drug) (IND = 60), or Celecoxib (10 mg/kg/day, cyclooxygenase-2-specific non-steroidal anti-inflammatory drug) (CEL = 60). Animals were sacrificed at 2, 4 and 8 weeks, and tissue was analysed.:Measures of outcome:Tissue analysis by gross inspection, biomechanical testing, histological analysis, collagen formation and maturation (polarised light microscopy).
Failure to heal: failure to heal was evident in four tendons in the CEL and one tendon in the IND group.
Collagen organisation and maturation: there was significantly less collagen organisation and maturation in the IND and CEL groups compared with CON at 4 and 8 weeks (p<0.001).
In an animal study of tendon-bone healing following rotator cuff repair, both a traditional non-selective as well as a cyclooxygenase-2-specific non-steroidal anti-inflammatory drugs inhibited tendon-to-bone healing.
The common practice of administering non-steroidal anti-inflammatory drugs following …